🇵🇱 INSTYTUT EKSPERTYZ SĄDOWYCH im. Prof. dra Jana Sehna PL

PCA AB 1567 • Kraków, 波兰 • 15 项方法

材料与高分子汽车

INSTYTUT EKSPERTYZ SĄDOWYCH im. Prof. dra Jana Sehna 是由 PCA 认可的实验室,认可编号 AB 1567(Kraków,波兰)。认可范围涵盖 15 项检测方法,涉及以下领域:材料与高分子、汽车。检测对象包括:Blood、人源材料、Blood and urine from living persons Blood, urine, vitreous humour a…、Blood and urine from living persons. Blood, urine, vitreous humour…。

要点速览

  • 认可编号: PCA AB 1567
  • 认可范围内方法数: 15
  • 检测对象种类: 12
  • 城市: Kraków, 波兰
认可编号
AB 1567
认可机构
PCA
地址
ul. Westerplatte 9, 31 – 033 Kraków
城市
Kraków, 波兰

该实验室检测什么 (12)

认可范围 — 项检测方法 (15)

序号 检测对象 方法 / 参数 技术 依据文件
检测方法
1 人源材料 Identification of the type of biological trace. Specific features of biological material. Method: Immunochromatographic and biochemical. Individualisation of biological traces. DNA analysis of polymorphic STR systems. Method: Multiplex PCR with capillary electrophoresis. Kinship analysis. DNA polymorphism analysis using STR systems. Method: Multiplex PCR with capillary electrophoresis. PB.G.011)
2 人源材料 生物痕迹个体识别。线粒体 DNA(mtDNA)多态性分析。DNA 测序法。 PB.G.021)
3 Blood and urine from living persons Blood, urine, vitreous humour and drip fluids from internal organs from corpses Ethyl alcohol concentration. Range: (0,10 – 16,0) ‰ Headspace gas chromatography with flame ionisation detection (HS-GC-FID) and spectrophotometric method (enzymatic ADH). PB.TA.01 wydanie 7 z dnia 27.11.2024
4 Blood and urine from living persons. Blood, urine, vitreous humour from corpses Ethyl alcohol concentration. Range: (0,10-20,0) ‰. Headspace gas chromatography with flame ionisation detection (HS-GC-FID) on two columns of different polarity PB.TA.02 wydanie 1 z dnia 27.11.2024
5 Blood Cannabinoid concentration Range: THC, CBD (1,0 - 20) ng/ml 11OH-THC (1,0 - 15) ng/ml THCCOOH, 7COOH-CBD (5 - 100) ng/ml HHC, HHCP, HHC acetate (1,0 - 20) ng/ml 11-OH-HHC (1,0 - 15) ng/ml HHCCOOH (5 - 100) ng/ml Amphetamine, methamphetamine, MDMA concentration Range: amphetamine (15 - 800) ng/ml methamphetamine, MDMA (15 - 400) ng/ml Cocaine and its metabolites concentration Range: cocaine (10 - 160) ng/ml benzoylecgonine, ecgonine methyl ester (50 - 800) ng/ml Opioid concentration Range: morphine, hydrocodone, naloxone, desomorphine, dextromethorphan (10 - 160) ng/ml codeine, EDDP, dextrorphan, oxycodone (10 - 320) ng/ml dihydrocodeine (20 - 160) ng/ml methadone (20 - 320) ng/ml, pethidine (50 - 3200) ng/ml tramadol (100 - 3200) ng/ml High-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) PB.TT.04 wydanie 2 z dnia 6.02.2025
6 Blood Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine, opioid, cocaine and benzoylecgonine derivatives Amphetamine derivatives expressed as amphetamine ≥ 25 ng/ml Methamphetamine derivatives expressed as MDMA ≥ 25 ng/ml Cannabinoids expressed as THCCOOH ≥ 5 ng/ml Benzodiazepine derivatives expressed as clonazepam ≥ 10 ng/ml Cocaine and benzoylecgonine expressed as benzoylecgonine ≥ 50 ng/ml Opioids expressed as morphine ≥ 10 ng/ml ELISA method PB.TT.01 wydanie 2 z dnia 15.12.2023
7 Urine Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine derivatives, opioids, cocaine and benzoylecgonine Amphetamine derivatives expressed as amphetamine ≥ 500 ng/ml Methamphetamine derivatives expressed as MDMA ≥ 500 ng/ml Cannabinoids expressed as THCCOOH ≥ 50 ng/ml Benzodiazepine derivatives expressed as oxazepam ≥ 300 ng/ml Cocaine and benzoylecgonine expressed as benzoylecgonine ≥ 300 ng/ml Opioids expressed as morphine ≥ 300 ng/ml ELISA method PB.TT.01 wydanie 2 z dnia 15.12.2023
8 Blood Presence of amphetamine, methamphetamine, cannabinoid, benzodiazepine and imidazopyridine, opioid, cocaine derivatives and cathinone derivatives Amphetamine derivatives Range: selegiline > 20 ng/ml amphetamine, methylphenidate, ephedrine > 25 ng/ml Methamphetamine derivatives Range: methamphetamine, MDMA, MDA, MDEA > 25 ng/ml Cannabinoids Range; THCCOOH, HHCCOOH > 5 ng/ml Benzodiazepine and imidazopyridine derivatives Range: flunitrazepam > 1 ng/ml alprazolam > 2 ng/ml clonazepam > 10 ng/ml diazepam, nordiazepam > 20 ng/ml midazolam > 30 ng/ml bromazepam > 50 ng/ml zolpidem > 80 ng/ml Cocaine derivatives (cocaine > 10 ng/ml; benzoylecgonine, ecgonine methyl ester >50 ng/ml) Opioids Range: fentanyl > 0,5 ng/ml buprenorphine > 1 ng/ml 6-MAM, dextromethorphan > 5 ng/ml codeine, methadone, morphine > 10 ng/ml thebaine > 20 ng/ml tramadol, EDDP > 50 ng/ml pethidine > 100 ng/ml Cathinone derivatives Range: mephedrone, 4-CMC > 5 ng/ml Method: high performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) PB.TT.02 wydanie 1 z dnia 29.07.2024
9 Impressions of finger and palm papillary lines Identification of fingerprint impressions. PB.KD.01 wydanie 12 z dnia 26.02.2025
10 Substrates – carriers of papillary line traces Visualization of fingermarks Techniques: - Visual examination, - DFO, - Ninhydrin, - 1,2 - IND, - Cyanoacrylate polymerization, - Basic Yellow 40, - Fingerprint powders of the type: ferromagnetic, light, special - Wet Powder, - Amido Black, - Acid Yellow 7, - Acid Violet 17, - Ardrox, - Hungarian Red, - DMAC, - Sudan Black. PB.KD.02 wydanie 3 z dnia 25.04.2025
11 Handwriting Identification testing of handwriting. Graphic-comparative method. PB.KP.01 wydanie 5 z dnia 07.01.2020
12 Documents Examination of alterations in documents. Optical methods (stereoscopic microscopy, near-infrared absorption analysis, luminescence analysis). PB.KP.02 wydanie 5 z dnia 07.01.2020
13 Impression of footwear soles, shoes Impression of tyres, tyres Class, individualising and individual features of footwear. Class, individualising and individual features of tyres. Toolmark examinations. PB.KM.01 wydanie 5 z dnia 08.12.2022
14 Fragments of single fibres, textiles Structural features of fibres and their colour. Identification and comparison examination of fibres. Optical microscopy and microspectrophotometry methods. PB.KM.02 wydanie 4 z dnia 07.05.2021
15 Fragments of paint coating Identification and comparative testing. Identification of the polymer binder, fillers, pigments, colour, structure. Infrared IR spectrometry method. PB.KM.03 wydanie 3 z dnia 07.01.2020

引用标准 (14)

PB.G.011)
PB.G.021)
PB.KD.01 wydanie 12 z dnia 26.02.2025
PB.KD.02 wydanie 3 z dnia 25.04.2025
PB.KM.01 wydanie 5 z dnia 08.12.2022
PB.KM.02 wydanie 4 z dnia 07.05.2021
PB.KM.03 wydanie 3 z dnia 07.01.2020
PB.KP.01 wydanie 5 z dnia 07.01.2020
PB.KP.02 wydanie 5 z dnia 07.01.2020
PB.TA.01 wydanie 7 z dnia 27.11.2024
PB.TA.02 wydanie 1 z dnia 27.11.2024
PB.TT.01 wydanie 2 z dnia 15.12.2023
PB.TT.02 wydanie 1 z dnia 29.07.2024
PB.TT.04 wydanie 2 z dnia 6.02.2025